ABQ plant to play a role in production of Covid-19 vaccine candidate for AstraZeneca

A drug product manufacturing facility in Albuquerque will be part of a global effort to deliver a vaccine to halt the spread of Covid-19 infections. Earlier this month, Albany Molecular Research Inc. announced it signed a supply agreement with AstraZeneca to support the manufacture of the pharmaceutical giant's Covid-19 vaccine candidate known as AZD1222, according to an AMRI news release. AstraZeneca spokesperson Brendan McEvoy confirmed the agreement with AMRI in an email to Albuquerque Business…